<ul><li>London-based Kiin Bio raises €1.9 million in a pre-Seed investment round to launch their Virtual Scientist Platform for drug discovery, KiinOS.</li><li>Funding round led by b2venture with participation from Heartfelt, rule30, and strategic angel investors to grow client base, enhance AI capabilities, and scale team.</li><li>Kiin Bio aims to streamline drug discovery process by unifying tools and data with an AI-driven platform, addressing the fragmented R&D challenges in the industry.</li><li>Founders bring expertise in AI, bioinformatics, and cloud infrastructure; Kiin Bio has initiated pilot projects, commercial partnerships, and won European grant for AI innovation.</li></ul>

London’s Kiin Bio raises €1.9 million to launch their Virtual Scientist Platform for drug discovery

Discover more